Cargando…
A 6-week, phase IIb, randomized, double-blind, placebo-controlled trial of Anyu Peibo capsules for the treatment of major depressive disorder in adults
BACKGROUND: Almost one-third of patients with major depressive disorder (MDD) do not respond to conventional antidepressants, and new treatments for MDD are urgently needed. OBJECTIVES: This phase IIb clinical trial was designed to evaluate the efficacy and safety of Anyu Peibo capsules in the treat...
Autores principales: | He, Shen, Yu, Yimin, Huang, Jingjing, Yin, Jiahui, Niu, Yajuan, Lu, Yazhou, Wu, Bin, Fang, Maosheng, Wang, Xue, Tao, Zhiping, Li, Lehua, Li, Kan, Li, Yan, Ding, Xiujuan, Shen, Yifeng, Li, Huafang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666694/ https://www.ncbi.nlm.nih.gov/pubmed/38022835 http://dx.doi.org/10.1177/20451253231212342 |
Ejemplares similares
-
The efficacy and safety of Anyu Peibo Capsule in the treatment of patients with major depressive disorder in China: study protocol for a randomized placebo-controlled trial
por: Huang, Jingjing, et al.
Publicado: (2021) -
Comparative Study on the Transcriptome of Maize Mature Embryos from Two China Elite Hybrids Zhengdan958 and Anyu5
por: Ma, Juan, et al.
Publicado: (2016) -
Effects of Chaihu-Shugan-San capsule for psychogenic erectile dysfunction: Study protocol of a randomized placebo-controlled trial
por: Ren, Feiqiang, et al.
Publicado: (2019) -
Characteristics and Spectrum of Cardiotoxicity Induced by Various Antipsychotics: A Real-World Study From 2015 to 2020 Based on FAERS
por: He, Luyao, et al.
Publicado: (2022) -
Analysis of the association of MIR124-1 and its target gene RGS4 polymorphisms with major depressive disorder and antidepressant response
por: Zeng, Duan, et al.
Publicado: (2018)